Search
for
Sort by
Research 121–150 of 1000+
- After Math of COVID Through Eyes of Tricoscopy
- Dermatological Manifestations of COVID-19 Patients
- Skin challenges in COVID-19 pandemic: The importance of cosmeceuticals
- Discovering the potential of natural remedies in the post COVID-19 complications based on in silico techniques
- A Retrospective Analysis from Turkey: The Effect of the COVID-19 Outbreak Quarantine on Dermatology Outpatient Clinics
- Covid-19 in Lupus Nephritis
- Autoimmune Liver Disease In Children
- Veterinary Pharmacology
- The Assessment and Treatment of Geezers
- MECHANISM OF PROTEINURIA
- PC039: Adverse effects at the level of marginal periodontium secondary to Finasteride administration
- Acquired Zinc Deficiency
- Contact Allergic Dermatitis to Quinine in an Anti-hair Loss Lotion
- Expression and roles of steroidogenic acute regulatory (StAR) protein in ‘non-classical’, extra-adrenal and extra-gonadal cells and tissues
- More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
- Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19
- Treatment of invasive aspergillosis with itraconazole
- The Rotterdam Study: 2016 objectives and design update
- The Dynamics of the Skin’s Immune System
- Severe cutaneous adverse reactions to drugs
- Dermatoses of pregnancy
- The PDGF/PDGFR pathway as a drug target
- Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection
- A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain – A potential clue to the role of androgens in COVID‐19 severity
- Recognition and management of <i>Staphylococcus aureus</i> toxin‐mediated disease
- Cutaneous manifestations of systemic lupus erythematosus
- Severe Acute Respiratory Syndrome Among Children
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- Lignans and Neolignans: Plant secondary metabolites as a reservoir of biologically active substances
- Significant Correction of Disease after Postnatal Administration of Recombinant Ectodysplasin A in Canine X-Linked Ectodermal Dysplasia